Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial.

ABSTRACT:

Importance

Financial incentives can improve medication adherence and cardiovascular disease risk, but the optimal design to promote sustained adherence after incentives are discontinued is unknown.

Objective

To determine whether 6-month interventions involving different financial incentives to encourage statin adherence reduce low-density lipoprotein cholesterol (LDL-C) levels from baseline to 12 months.

Design, setting, and participants

This 4-group, randomized clinical trial was conducted from August 2013 to July 2018 among several large US insurer or employer populations and the University of Pennsylvania Health System. The study population included adults with elevated risk of cardiovascular disease, suboptimal LDL-C control, and evidence of imperfect adherence to

SUBMITTER: Barankay I 

PROVIDER: S-EPMC7547367 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature